Search research articles
Contact Us
Filters
Showing results (41-50 of 144) with videos related to
Page
of 15
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses
Richard Harrop, Noel Drury, William Shingler, et al.
Nucleic Acids Research
|
February 19, 2025
Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time
Xiaofeng Dong, David A Matthews, Giulia Gallo, et al.
Scientific Reports
|
June 24, 2017
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product
Stuart D Dowall, Frédéric Jacquot, John Landon, et al.
Genome Medicine
|
July 30, 2020
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Andrew D Davidson, Maia Kavanagh Williamson, Sebastian Lewis, et al.
Journal of Translational Medicine
|
January 9, 2009
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma
Howard L Kaufman, Bret Taback, William Sherman, et al.
The Journal of Infectious Diseases
|
June 17, 2026
Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease
Jocelyn G Pérez, Natasha Y Rickett, Stephan Günther, et al.
Frontiers in Cellular and Infection Microbiology
|
October 8, 2021
Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection
Matthew Charman, Steven McFarlane, Joanna K Wojtus, et al.
European Journal of Medicinal Chemistry
|
April 12, 2025
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies
Dóra Laczi, Sofia Schönbauer Huamán, Taylah Andrews-Clark, et al.
Genome Medicine
|
January 12, 2021
Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care
Andrew Bosworth, Natasha Y Rickett, Xiaofeng Dong, et al.
Emerging Infectious Diseases
|
November 22, 2016
Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014-2015
Mory Keita, Sophie Duraffour, Nicholas J Loman, et al.
Page
of 15
Search research articles
Search
Showing results (41-50 of 144) with videos related to
Sort By:
Page
of 15
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 3, 2007
Vaccination of colorectal cancer patients with modified vaccinia ankara encoding the tumor antigen 5T4 (TroVax) given alongside chemotherapy induces potent immune responses
Richard Harrop, Noel Drury, William Shingler, et al.
Nucleic Acids Research
|
February 19, 2025
Using minor variant genomes and machine learning to study the genome biology of SARS-CoV-2 over time
Xiaofeng Dong, David A Matthews, Giulia Gallo, et al.
Scientific Reports
|
June 24, 2017
Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product
Stuart D Dowall, Frédéric Jacquot, John Landon, et al.
Genome Medicine
|
July 30, 2020
Characterisation of the transcriptome and proteome of SARS-CoV-2 reveals a cell passage induced in-frame deletion of the furin-like cleavage site from the spike glycoprotein
Andrew D Davidson, Maia Kavanagh Williamson, Sebastian Lewis, et al.
Journal of Translational Medicine
|
January 9, 2009
Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma
Howard L Kaufman, Bret Taback, William Sherman, et al.
The Journal of Infectious Diseases
|
June 17, 2026
Identification of host gene transcripts by machine learning and their application to predict outcome in Ebola virus disease
Jocelyn G Pérez, Natasha Y Rickett, Stephan Günther, et al.
Frontiers in Cellular and Infection Microbiology
|
October 8, 2021
Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection
Matthew Charman, Steven McFarlane, Joanna K Wojtus, et al.
European Journal of Medicinal Chemistry
|
April 12, 2025
Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies
Dóra Laczi, Sofia Schönbauer Huamán, Taylah Andrews-Clark, et al.
Genome Medicine
|
January 12, 2021
Analysis of an Ebola virus disease survivor whose host and viral markers were predictive of death indicates the effectiveness of medical countermeasures and supportive care
Andrew Bosworth, Natasha Y Rickett, Xiaofeng Dong, et al.
Emerging Infectious Diseases
|
November 22, 2016
Unusual Ebola Virus Chain of Transmission, Conakry, Guinea, 2014-2015
Mory Keita, Sophie Duraffour, Nicholas J Loman, et al.
Page
of 15